Marianne De Backer - Apr 3, 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Chief Executive Officer
Signature: /s/ Vanina de Verneuil, Attorney-in-Fact
Stock symbol: VIR
Transactions as of: Apr 3, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/4/2023, 04:53 PM
Previous filing: Jan 11, 2023
Next filing: Jun 26, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Award	$0	+576K		$0.00	576K	Apr 3, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Award	$0	+1.15M		$0.00	1.15M	Apr 3, 2023	Common Stock	1.15M	$23.28	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
F2	25% of the shares subject to the stock option vest and become exercisable on April 3, 2024, and the remainder vest in 36 equal monthly installments thereafter.